Gruppo di biostatistica per la ricerca di base ed il controllo di qualità
Pubblicazioni recenti
1.
Pardini B, Verderio P, Pizzamiglio S, Nici C; Maiorana MV, Naccarati A, Vodickova L, Vymetalkova V,
Veneroni S, Daidone MG, Ravagnani F, Bianch T, Bujanda L, Carracedo A, Castells A, Ruiz-Ponte C, Morreau H,
Howarth K, Jones A, Castellví-Bel S, Li L, Tomlinson I, Van Wezel T, Vodicka P, Radice P, Peterlongo P.
Association between Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study. PLoS One 2014 [in press]
2.
Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Azzeni A, Perrone F, Leo E, Pilotti S, Verderio P, Gariboldi M and
Pierotti MA. Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal. British
Journal of Cancer 2014 [Epub ahead of print]
3.
Perrone F, Lampis A, Bertan C, Verderio P, Ciniselli CM, Pizzamiglio S, Frattini M, Nucifora M, Molinari F,
Gallino G, Gariboldi M, Meroni E, Leo E, Pierotti MA , Pilotti S. Circulating free dna in a screening programme for early colorectal cancer detection. Tumori 2013 [in press]
4.
Cuorvo LV, Verderio P, Ciniselli CM, Girlando S, Decarli N, Leonardi E, Ferro A, Caldara A, Triolo R, Eccher C,
Cantaloni C, Mauri F , Seckl M, Volante M, Buttitta F, Marchetti A, Quattrone S, Galligioni E, Dalla Palma P,
Barbareschi B. PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy. Virchows Archiv. 2013 [Epub ahead of print]
5.
Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C,
Agresti R, Daidone MG, Morelli D, Camaschella C,Verderio P and Bongarzone I. Hepcidin and Ferritin blood level as non-invasive tools for predicting breast cancer. Annals of Oncology 2013 [Epub ahead of print]
6.
Pizzamiglio S, Bottelli S, Ciniselli CM, Zanutto S, Bertan C, Gariboldi M, Pierotti MA, Verderio P. A normalization strategy for the analysis of plasma microRNA qPCR data in colorectal cancer. Int J Cancer. 2013. doi: 10.1002/ijc.28530. [Epub ahead of print]
7.
Terrenato I, Arena V, Pizzamiglio S, Pennacchia I, Perracchio L, Buglioni S, Ercolani C, Sperati F, Costarelli L,
Bonanno E, Baldini D, Candia S, Crescenzi A, Dal Mas A, Di Cristofano C, Gomes V, Grillo LR, Pasquini P,
Pericoli MN, Ramieri MT, Di Stefano D, Ruco L, Scarpino S, Vitolo D, D Amati G, Paradiso A, Verderio P,
Mottolese M. External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale. J Exp Clin
Cancer Res. 2013;32:58. [Epub ahead of print]
8.
Malentacchi F, Pazzagli M, Simi L, Orlando C, Wyrich R, Hartmann CC, Verderio P, Pizzamiglio S, Ciniselli CM,
Tichopad A, Kubista M, Gelmini S. SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. Clin Chim Acta. 2013;424:274-86.
9.
Musella V, Verderio P, Reid JF , Pizzamiglio S , Gariboldi M, Callari M, Milione M, De Cecco L, Veneroni S,
Pierotti MA, Daidone MG. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One. 2013;8:e53406.
10.
Salvianti S, Pinzani P, Verderio P, Ciniselli CM, Massi D, De Giorgi V, Grazzini M, Pazzagli M, Orlando C.
Multiparametric analysis of cell-free dna in melanoma patients. PLoS One. 2012;7:e49843.
11.
Manoukian S, Verderio P, Tabano S, Colapietro P, Pizzamiglio S, Grati FR, Calvello M, Peissel B, Burn J,
Pensotti V, Allemani C, Sirchia SM, Radice P, Miozzo M. X chromosome inactivation pattern in BRCA gene mutation carriers. Eur J Cancer. 2013;49:1136-41.

12.
Verderio P, Ciniselli CM, Pizzamiglio S. Comment to "Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease". Dig Liver Dis. 2013;45:265
13.
Pazzagli M, Malentacchi F, Simi L, Orlando C, Wyrich R, Günther K, Hartmann C, Verderio P, Pizzamiglio S,
Ciniselli CM, Tichopad A, Kubista M, Gelmini S. SPIDIA-RNA: First External Quality Assessment for the preanalytical phase of blood samples used for RNA based analyses. Methods. 2013;59:20-31.
14.
Gronchi A, Verderio P, De Paoli A, Ferraro A, Tendero O, Majò J, Martin J, Comandone A, Grignani G,
Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Palassini E, Stacchiotti S, Ferrari F, Fiore M and
Casali PG. Quality of surgery and neoadjuvant combined therapy in the isg-geis trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 2013;24:817-23.
15.
Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B,
Kconfab, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M,
Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P.
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Hum Mutat. 2012;33:1665-75.
16.
Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, Martin J, Comandone A, Cruz J,
Ferraro A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Casali PG, Gronchi A.
Tumor response assessment by modified Choi criteria in localized highrisk soft tissue sarcoma treated with chemotherapy: an exploratory analysis on a Phase III trial. Cancer 2012; 118:5857-66.
17.
Verderio P. Assessing the clinical relevance of oncogenic pathways in neoadjuvant breast cancer. J Clin Oncol.
2012; 30:1912-5.
18.
Günther K, Malentacchi F, Verderio P, Pizzamiglio S, Ciniselli CM, Tichopad A, Kubista M, Wyrich R, Pazzagli
M, Gelmini S. Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. Clin Chim Acta. 2012; 413:779-86.
19.
Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall'olio V, Sardella D, Ravagnani F, Galastri L, Barile M, Peissel
B, Zaffaroni D, Manoukian S, Radice P, Peterlongo P. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat. 2012; 133:805-7.
20.
Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, Mariani L, Valagussa P, Miceli R,
Stacchiotti S, Tos AP, De Paoli A, Longhi A, Poveda A, Quagliuolo V, Comandone A, Casali PG, Picci P. Short,
Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 2012; 30:850-6.
21.
Perotti D, Spreafico F, Torri F, Gamba B, D’Adamo P, Pizzamiglio S, Terenziani M, Catania S, Collini P, Nantron
M, Pession A, Bianchi M, Indolfi P, D’Angelo P, Fossati-Bellani F, Verderio P, Macciardi F, Radice P. Genomic
Profiling by Whole-Genome Single Nucleotide Polymorphism (SNP) Arrays in Wilms Tumor and Association with
Relapse. Genes Chromosomes and Cancer. 2012; 51:644-53.
22.
Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G,
Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA. MicroRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res. 2012;10:504-15.
23.
Catucci I, Colombo M, Verderio P, Bernard L, Ficarazzi F, Mariette F, Barile M, Peissel B, Cattaneo E, Manoukian
S, Radice P, Peterlongo P. Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases,
PLoS One. 2012;7:e31038.
24.
Zanutto S, Pizzamiglio S, Lampis A, Camerini T, Di Mauro MG, Pierotti MA, Verderio P, Gariboldi M.
Methylation status in early stage colon cancer patients: A new prognostic marker?.Int J Cancer. 2012;130:488-9.